Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study (NCT06729736) | Clinical Trial Compass
By InvitationNot Applicable
Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study
South Korea500 participantsStarted 2024-12-01
Plain-language summary
The goal of this study is to implement and investigate the efficacy of an Early Recovery After Surgery (ERAS) protocol in South Korean colorectal cancer patients.
The primary outcome will be the postoperative time taken to achieve the 'discharge criteria'.
Secondary outcomes will include adherence, hospital stay, early complications, mortality, pain scores, re-admission and quality of life questionnaire scores.
As a single arm study, all participants will be treated according to an ERAS protocol, which includes components such as early ambulation, minimal fasting, multimodal pain control and omission of- or early removal of invasive catheters.
Who can participate
Age range
19 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Above the age of 19 years
* Pathologic diagnosis of colon cancer or rectal cancer
* Scheduled for minimally invasive (laparoscopic or robotic) colorectal cancer surgery
* Agreed to participate after a detailed explanation of the study
Exclusion Criteria:
* Stage 4 (distant metastasis)
* Emergency surgery
* Scheduled for transanal surgery
* Perforated colorectal cancer
* Obstructed colorectal cancer
* Familial colorectal cancer (HNPCC, FAP, MUYH polyposis, Peutz-Jeghers syndrome)
* Previous treatment for colorectal cancer
* History of other cancer within 5 years (excluding skin cancer)
* Acute infection
* Unable to read or understand the study
* Mental impairment
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Postoperative time to discharge criteria
Timeframe: From the date of surgery until the date of first achieving all of the discharge criteria, assessed up to 100 days